1 / 37

Staphylococcal Toxic Shock Syndrome: A Case Presentation

This case presentation discusses a 19-year-old female who presents with diarrhea, vomiting, and a rash. The possible diagnosis is Staphylococcal Toxic Shock Syndrome.

dovied
Download Presentation

Staphylococcal Toxic Shock Syndrome: A Case Presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case Presentation By Ahmed Abudeif Abd Elaal Resident in Tropical Medicine & Gastroenterology Department

  2. Case • 19 years old female • C/O diarrhea and vomiting. • Sudden onset, profuse for last 8-10 hrs • Some diffuse abdominal pain • Presents to ED in evening: • BP 100/65 P 95 T 37.8 • Looks anxious, feels weak, has been tolerating PO for last hour

  3. Case cont... • History of present illness: • No prodrome • No antibiotics in last 6 months • Not pregnant: started menses 3 days ago. • Travel: came back from Costa Rica 3 weeks ago, lived in families, has not been sick since • Past medical history: • No previous sexual history. • Never get pregnant.

  4. Case cont... • O/E: • Dry mouth. • Heart: Free. • Chest: Free. • Abdomen: Slightly distended, Bowel sounds +, diffuse tenderness, no guarding, no rebound. • Skin: Normal.

  5. Case cont... • Staff comes in... • Looks sick. • Asks for rectal T: 40. • Orders: • IV: 1L NS bolus • CBC, SMA-7 (BUN, Serum Cl, CO2, Creatinine, Blood glucose, Serum K and Serum Na), LFT’s, blood cultures • U/A and culture. • B-HCG. • Stool cultures, parasites, and C.Diff.

  6. Case cont... • Results: • WBC 13,500 • U/A : RBC ++++, 1-5 leukos • Creat 86 • Hb 13.9 • Platelets 190 • Urinary B-HCG -ve

  7. Case cont... • Diagnosed Pyelonephritis? • Started on Cipro • Observed in ER • 4 hrs later, weakness and syncope • BP: 90/40, confused • Non-pitting edema of face and neck • Sent to ressucitation • Volume ressucitated

  8. Case cont... • LABs repeated: • Creat 86, now 100 • Hb 13.9 now 9 • Platelets 190 now 100 • U/S abdomen and pelvis: • splenomegaly 16 cm • mesenteric adenitis • normal otherwise

  9. What is the possible Diagnosis?

  10. And now... • Patient develops a rash which is erythematous maculopapular :

  11. Case cont... • Our patient: • Blood cultures – ve • Monotest – ve • Vaginal swab + ve for staph aureus • Urine culture – ve • C. Diff – ve in stools • Specific toxins search at Winnipeg. Results pending.

  12. What is the possible Diagnosis?

  13. Staphyloccocal Toxic Shock Syndrome (STTS)

  14. STSS - Historical 1978 – Todd and Fishaut first describe STSS • Acute febrile illness in 7 children • Development of shock • Association w staphylococcus aureus 1981 –US epidemic • TSS identified in 941 pts • 812 menstrual cases; otherwise healthy women • Association w hyperabsorbant tampons use Drastic drop in incidence since 1980 Now 50% of case are non menstrual

  15. Toxic shock syndrome and tampons : the risk remains • US: annual incidence STSS: • 1-5 cases per 100 000 women in menstruation • > 90% in female 15-19y • Mortality 3.3%

  16. STSS – Risk factors • Menses • Tampons : increased risk 33 times in susceptible women • Nasal packing • Young age • Previous STSS • Vaginal – postpartum or following abortion • Surgical wounds: hernia repair, mammoplasty, arthroscopy • Septorhinoplasty • Influenza or influenza-like illness

  17. STSS – Pathogenesis • Toxic shock syndrome toxin-1 (TSST-1) • 90-100% of mentrual-related cases (MRTSS) • 40-60% of nonmenstrual cases (NMTSS) • Enterotoxin B: 23% • Enterotoxin C: 2% • Enhanced production: • Neutral vaginal pH • Increase in vaginal pO2 and pCO2 • Synthetic fibers in tampon composition

  18. STSS – Pathogenesis • TSST-1 & enterotoxins = Superantigens: • Nonspecific T-lymphocyte stimulation without normal antigenic recognition • Ad 20% Result: massive production of cytokines • Release of IL-1, IL-2, TNF, interferon

  19. STSS – Pathogenesis • Immune response from host plays an important role in pathogenesis • 70-80% of 18 y.o. have antibodies to TSST-1 • 90-95% at 40 y.o.

  20. STSS – Clinical presentation • Symptoms on presentation: • Tachycardia 80%. • Fever 70-81%. • Hypotension 44-65%. • Confusion 55%. • Localized erythema 44-65%. • Scarlatin-like rash 4%.

  21. STSS – Clinical presentation • Rapid onset of symptoms: • Day 3-4 of menses. • Day 2 post-operative.

  22. STSS – Clinical presentation

  23. STSS – Clinical presentation

  24. STSS – Diagnostic criteria • CDC 1990: Clinical manifestations • Fever >38.9. • Rash – diffuse macular erythroderma. • Desquamation – 1-2 after onset, palms and soles. • Hypotension (SBP<90 mmHg). • Multisystem involvement (3 or more): • GI (Vomiting, diarrhea, abdominal pain) at onset of illness. • Muscular (myalgias, CPK X2). • Mucous membrane (vagnal, oropharyngeal or conjunctival hyperemia). • Renal (Creat X2 or sterile pyuria). • Hepatic (bilirubin or ALT X2). • Hematologic (plt <100 000). • CNS (disorientation and alteration in consciousness).

  25. STSS – Diagnostic criteria • CDC 1990: Laboratory criteria • Negative results on the following tests , if obtained: • Serologic test for Rocky Mountain spotted fever, leptospirosis, measles • Blood, throat, CSF cultures (blood cultures may be + for Staph aureus)

  26. STSS – Diagnostic criteria • CDC 1990: Case classification • Definite case: all 6 criterias • Probable case: 5 on 6 criterias In the absence of clinical markers, strict application is warranted • Excludes subclinical cases • Self-limited

  27. STSS – Diagnosis • Isolation of Staphyloccocus aureus productor of exotoxins in a pt w compatible clinical picture • Not necessary for diagnosis • Help in suspected cases • RARELY isolated in blood

  28. Case cont... • Our patient: • Age 19 years old. • T > 38.9. • Diffuse rash. • Hypotension. • Multisystem involvement: • Diarrhea, Vomiting • Alteration in consciousness • Renal but not sufficient to meet the criteria • Plts 100 000 • Desquamation? Others tests – ve? • Probable case.

  29. STSS - Treatment • Treatment of support: • Agressive fluid support w isotonic NS or colloids: ad 10-20 L/24 hres • Vasopressor/inotrope infusion as necessary • Surgical treatment: • Removal of foreign objects: • Tampons • Nasal packing • Surgical debridement of scars: even if wound doesn’t look bad • I & D if abcess

  30. STSS - Treatment Therapy guided at stopping toxin production • Antimicrobial agents: • Have not been shown to affect outcome • IN VITRO: • Clindamycin inhibits protein synthesis – inhibition of TSST-1 • Anti-staph penicillin, cephalosporin may promote TSST-1 production • No clinical studies

  31. STSS - Treatment Therapy guided at stopping toxin production • Antimicrobial agents: • Recommandation: • Clindamycin 900 IV q8 +/- Cloxacillin 2g IV q12 • Clindamycin 900 IV q8 +/- Vancomycin 1g IV q12 for MRSA.

  32. STSS - Treatment • Additional therapies: • Consider Intravenous immunoglobulin (IVIG): • If patients remains unstable • Contains antibodies to TSST-1 • Sporadicaly reported to have salutary effect; controlled trials are incomplete • Corticosteroids: • May accelerate clinical improvement and diminish neurologic sequelae.

  33. Case: evolution • Treatment: • Cloxacillin + Tazocin IV X 2 d • then Cloxacillin IV x 4 d • then Cephalexin PO x 4 d • Hemodynamic stabilisation w 4 L NS and 2 L of Pentaspan the first night. • No need for inotropes or additionnal therapies. • Progressive improvement of general condition.

  34. Thank you

More Related